4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-020471
Chief Scientific Officer sold 1,384 shares at $0.34 ($471)
- Chief Scientific Officer acquired 9,092 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loose Christopher R. · Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,546 | 54,596 | D | ||
| 2023-07-06 | Exercise or conversion : show line 2 in the form 10b5-1 | +4,546 | 59,142 | D | ||
| 2023-07-06 | Sale : show line 3 in the form 10b5-1 | −1,384 | $0.34 | $471 | 57,758 | D |
| Open-market sales · 1,384 sh · avg $0.34 · $471 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2023-07-05 | Exercise or conversion : show line 4 in the form 10b5-1 Restricted Stock Unit | −4,546 | 4,546 | 145,454 | D |
| 2023-07-06 | Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Unit | −4,546 | 4,546 | 140,908 | D |
Loading xslF345X04/form4.xml…